ST VINCENT MEDICAL CENTER
1. Target Overview & Investment Thesis
ST VINCENT MEDICAL CENTER is a 483-bed suburban community hospital in LUCAS, OH with $802.0M in net patient revenue and a -10.9% operating margin. The hospital serves a payer mix of 21.1% Medicare, 3.3% Medicaid, and 75.6% commercial.
Thesis: Undervalued. Our ML models identify $59.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -10.9% to -3.6% (+736bps).
| Net Revenue HCRIS | $802.0M |
| Current EBITDA COMPUTED | $-87.7M |
| Operating Margin COMPUTED | -10.9% |
| Occupancy HCRIS | 65.3% |
| Revenue / Bed COMPUTED | $1.7M |
| Net-to-Gross HCRIS | 15.1% |
| Distress Probability ML | 43.1% |
2. Market Context & Competitive Position
OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -10.9% places it below the state median. Among 31 size-comparable peers (242-966 beds), the median margin is 0.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (242-966), prioritizing same-state peers. 31 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ST VINCENT MEDICAL CENTER (Target) | OH | 483 | $802.0M | -10.9% |
| CHILDRENS HOSPITAL MEDICAL CEN | OH | 711 | $2.51B | -20.1% |
| UH CLEVELAND MEDICAL CENTER | OH | 660 | $2.22B | -5.0% |
| NATIONWIDE CHILDRENS HOSPITAL | OH | 694 | $2.05B | 8.1% |
| ARTHUR G JAMES CANCER HOSPITAL | OH | 356 | $1.95B | 21.0% |
| RIVERSIDE METHODIST HOSPITAL | OH | 743 | $1.70B | 3.4% |
| THE TOLEDO HOSPITAL | OH | 732 | $1.34B | 0.8% |
| UNIVER.OF CINCINNATI MED CENTE | OH | 542 | $1.30B | 2.8% |
| MIAMI VALLEY HOSPITAL | OH | 893 | $1.29B | 9.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $59.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $16.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $16.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $15.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $9.8M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $513K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-87.7M |
| + RCM Uplift | +$59.0M |
| Pro Forma EBITDA | $-28.7M |
| Current Margin | -10.9% |
| Pro Forma Margin | -3.6% |
| WC Released (1x) | $30.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-134.9M | $11.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-134.9M | $-30.8M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-121.4M | $120.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-121.4M | $95.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-148.4M | $-239.6M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-148.4M | $-311.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 31 hospitals with 242-966 beds
- Same-state prioritization (n=32)
- Comp margins: P25=-5.6% / P50=0.6% / P75=6.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.